Mechanistically, AT1R activation in melanoma cells enhances the expression of matrix metalloproteinase-9 (MMP-9), a crucial mediator of invasion and metastasis, through the activation of the MAPK pathway [121].Valsartan inhibited this signaling cascade via AT1R blockade, thereby reversing resistance to BRAF inhibitors. The gene discussed is MMP9; the disease is melanoma.